Author

F. Vaz

View on Semantic Scholar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial.

E. Koene, V. Schrauwen-Hinderling, Jeremy Basset-Sagarminaga et al. · Nature Metabolism · 1 citation

Open access Aug 2026

Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation

In vivo FLAP antagonism ameliorates disease severity and spinal cord inflammatory gene expression in the experimental autoimmune encephalomyelitis model, an animal model of MS, in both a prophylactic and therapeutic settings.

J. Konings, Fleur Mingneau, Serhii Chornyi et al. · Acta Neuropathologica · 0 citations